TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
about
Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the LiteratureIdiosyncratic adverse drug reactions: current conceptsWhat is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.Possible association of etanercept, venous thrombosis, and induction of antiphospholipid syndrome.NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab.Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsAppearance of ANCA - associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment.Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesAdalimumab induced pulmonary sarcoid reaction.Cardiac Tamponade as a Presenting Manifestation of Infliximab-Induced Lupus in Patient Treated for Crohn's Disease.Etanercept: efficacy and safety for approved indications.Chilblain lupus induced by TNF-α antagonists: a case report and literature review.Comparative efficacy of biologics in psoriasis: a review.A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?Certolizumab pegol in axial spondyloarthritis.Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.Adverse reactions to biologic agents and their medical management.Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events.Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis.Trigger factors of cutaneous lupus erythematosus: a review of current literature.Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.The safety of vedolizumab for ulcerative colitis and Crohn's disease.Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa.Glomerular cytokine expression in murine lupus nephritis.Biologics in dermatology: adverse effects.Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases.Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic.[Secukinumab-induced subacute-cutaneous lupus erythematosus].A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus.Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome
P2860
Q26785523-44565D5C-9D87-4D40-9ED8-FDBF093CF393Q26824391-C808D070-A4CC-4E36-BD8B-3804AF7273B4Q30826279-C12CEB97-EB29-4D72-8206-4C4E4DB2A63FQ33737258-5E2630D3-98EE-4097-9421-89A876E514F5Q33816779-E401DFDD-2D91-484A-9276-CE98824FD158Q34031291-0BFC1D81-F456-4AFD-B28C-B7C9C0CF7B79Q34790990-0B1D667F-F1F8-4F25-B8E4-0280372F8C57Q35967249-787C7C48-9883-42A1-994A-072580B07178Q36418745-7C10B56E-E079-4E5C-89A4-32753E0F359AQ36579988-AD35029A-8E2D-4552-9B73-5B5F60CF9D57Q36746668-89611E6B-7FC5-418F-8530-0D62E8A48EF0Q37354812-75BDE583-8DD7-4654-9C77-346B9DC4AE19Q37576496-3DC6F749-3E3A-49DF-B342-1F68A163E53EQ37593973-9C74E12F-195F-467B-85DF-4258C320792EQ37954714-338424A7-F4F2-4B15-8011-8993ECA28242Q37972243-8BD791A1-0107-45EE-8D2D-3E2122B0A9F4Q38042475-4680C079-9C78-4FFC-8F26-F5CB80184E19Q38129797-F761F3B1-9664-4F98-8CCB-22CC71C9EE29Q38161555-D26B42C1-0C0F-45D5-B431-69CA30353176Q38179468-B53311FA-C7FD-4E68-8737-42EC4A67FBE0Q38190033-5F555A21-9D9B-4FB1-90FF-81DD990BB541Q38238948-027F3E0D-82E8-4C95-849C-D6259B86DB84Q38394816-7D5A3D85-BAE0-410F-9347-8B861DDFEA00Q38663608-F5D1FAAD-6672-4E68-AE78-32E5939DAD07Q38755133-14A2A332-6E54-4355-BFAF-475C794D7305Q38973692-65AB2BC4-334B-4F8F-8E63-E9DC218ECC4CQ39259474-21DE254D-A4B0-4BEE-A1C7-CCD8F204A9C6Q39985219-57AC5BB8-8826-46B4-8BF4-8C9CFC85B3E0Q40331791-8E39BEDE-D278-446A-9CE1-F17EC1EEF7B5Q40927712-8F37A0B8-281E-4173-B637-46C8C6D70F35Q41120913-0E10F33A-D43E-47B3-855A-D6517F2FADA4Q46068495-474B2A8A-B289-466B-9D26-174FC4D790E9Q46252749-0AB766E5-00B4-4A16-B82D-7C08D9691F86Q47831413-31CAF0BD-268C-47FD-97F1-9BF9D54BD843Q48140916-E996B4BD-CD2F-49AF-9D4C-B736002E9CB8Q48298265-59F71550-891B-4AEA-A669-1D6BC9AF8F51Q50093692-2E122EB8-A22B-48B6-9B47-AC76E48194BEQ51140270-6A85A4E6-34CE-4E20-BD7B-D7AF2F994251Q58134824-B35D9074-45EB-4148-9241-A2850FB78CEB
P2860
TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@en
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@nl
type
label
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@en
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@nl
prefLabel
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@en
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@nl
P2860
P1476
TNF alpha antagonist-induced l ...... rnative TNF alpha antagonists.
@en
P2093
Philip R Cohen
Victoria L Williams
P2860
P304
P356
10.1111/J.1365-4632.2011.04871.X
P577
2011-05-01T00:00:00Z